Details of Disease
General Information of Disease (ID: DISINP9B)
Disease Name | Autosomal recessive limb-girdle muscular dystrophy type 2I | |||||
---|---|---|---|---|---|---|
Synonyms |
muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5; muscular dystrophy, limb-girdle, type 2I; muscular dystrophy-dystroglycanopathy, limb-girdle, Frkp-related; limb-girdle muscular dystrophy type 2I; muscular dystrophy limb-girdle type 2I; muscular dystrophy-dystroglycanopathy (limb-girdle), type C5; muscular dystrophy-dystroglycanopathy (Limb-girdle) type C, 5; muscular dystrophy-dystroglycanopathy limb-girdle FRKP-related; autosomal recessive limb-girdle muscular dystrophy caused by mutation in FKRP; LGMD2I; MDDGC5; FKRP autosomal recessive limb-girdle muscular dystrophy; muscular dystrophy-dystroglycanopathy (limb-girdle) type C 5; LGMD-FKRP related; limb-girdle muscular dystrophy due to FKRP deficiency
|
|||||
Definition |
A subtype of autosomal recessive limb-girdle muscular dystrophy that presents a highly variable age of onset and phenotypic spectrum typically characterized by slowly progressive proximal weakness of the pelvic and shoulder girdle musculature (predominantly affecting the lower limbs), frequently associated with waddling gait, scapular winging, calf and tongue hypertrophy, exercise-induced myalgia, and myoglobinuria and/or elevated creatine kinase serum levels. Abdominal muscle weakness, cardiomyopathy, respiratory muscle involvement and various brain abnormalities have also been reported.
|
|||||
Disease Hierarchy | ||||||
Disease Identifiers | ||||||
Molecular Interaction Atlas (MIA) of This Disease
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
This Disease Is Related to 1 DOT Molecule(s)
|
|||||||||||||||||||||||||